Phase II trial of nab- sirolimus in patients with Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-term efficacy and safety update

Authors

Andrew J Wagner, Harvard University
Vinod Ravi, University of Texas MD Anderson Cancer Center
Richard F Riedel, Duke University
Kristen Ganjoo, Stanford University
Brian A Van Tine, Washington University School of Medicine in St. Louis
Rashmi Chugh, University of Michigan - Ann Arbor
Lee Cranmer, University of Washington
Erlinda M Gordon, Sarcoma Oncology Center
Jason L Hornick, Brigham and Women's Hospital
Heng Du, Brigham and Women's Hospital
Li Ding, Aadi Bioscience Inc
Anita N Schmid, Aadi Bioscience Inc
Willis H Navarro, Aadi Bioscience Inc
David J Kwiatkowski, Brigham and Women's Hospital
Mark A Dickson, Weill Cornell Medical College

Journal

Journal of Clinical Oncology

Publication Date

5-1-2024

Volume

42

Issue

13

First Page

1472

Last Page

1476

Document Type

Open Access Publication

DOI

10.1200/JCO.23.02266

Rights and Permissions

Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R, Cranmer L, Gordon EM, Hornick JL, Du H, Ding L, Schmid AN, Navarro WH, Kwiatkowski DJ, Dickson MA. Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. J Clin Oncol. 2024 May 1;42(13):1472-1476. doi: 10.1200/JCO.23.02266. © 2024 by American Society of Clinical Oncology. Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/

Recommended Citation

Wagner, Andrew J; Ravi, Vinod; Riedel, Richard F; Ganjoo, Kristen; Van Tine, Brian A; Chugh, Rashmi; Cranmer, Lee; Gordon, Erlinda M; Hornick, Jason L; Du, Heng; Ding, Li; Schmid, Anita N; Navarro, Willis H; Kwiatkowski, David J; and Dickson, Mark A, "Phase II trial of nab- sirolimus in patients with Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-term efficacy and safety update." Journal of Clinical Oncology. 42, 13. 1472 - 1476. (2024).
https://digitalcommons.wustl.edu/oa_4/4114

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.